Evidence map›Paper›PMID 29066313›Full record

ArticleBone2018

Ex vivo replication of phenotypic functions of osteocytes through biomimetic 3D bone tissue construction.

Qiaoling Sun, Saba Choudhary, Ciaran Mannion, Yair Kissin, Jenny Zilberberg, Woo Y Lee

Abstract read
In one paragraph

Article in Bone, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Biomedical materials (Bristol, England) · 2022
    Article
  8. Osteon: Structure, Turnover, and Regeneration.Tissue engineering. Part B, Reviews · 2022
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Establishment ofExperimental and therapeutic medicine · 2020
    Article
  17. New and Old Osteocytic Cell Lines and 3D Models.Current osteoporosis reports · 2020
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Qiaoling SunDepartment of Materials Science and Chemical Engineering, Stevens Institute of Technology, Hoboken, NJ, USA.
Saba ChoudharyDepartment of Biomedical Engineering, Chemistry and Biological Sciences, Stevens Institute of Technology, Hoboken, NJ, USA.
Ciaran MannionDepartment of Pathology, Hackensack University Medical Center, Hackensack, NJ, USA.
Yair KissinDepartment of Orthopeidc Surgery, Hackensack University Medical Center, Hackensack, NJ, USA.
Jenny ZilberbergDepartment of Biomedical Research, Hackensack University Medical Center, Hackensack, NJ, USA.
Woo Y LeeDepartment of Materials Science and Chemical Engineering, Stevens Institute of Technology, Hoboken, NJ, USA. Electronic address: wlee@stevens.edu.
Hackensack University Medical Center · USStevens Institute of Technology · US

Funding

Microfluidic 3D Culture of Primary OsteocytesR21AR065032 · NIAMS · THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY · PI LEE, WOO YOUNG · 2013 to 2014
$348k
NIAMS NIH HHS R21 AR065032
6 · The paper itself

Abstract

Osteocytes, residing as 3-dimensionally (3D) networked cells in bone, are well known to regulate bone and mineral homeostasis and have been recently implicated to interact with cancer cells to influence the progression of bone metastases. In this study, a bone tissue consisting of 3D-networked primary human osteocytes and MLO-A5 cells was constructed using: (1) the biomimetic close-packed assembly of 20-25μm microbeads with primary cells isolated from human bone samples and MLO-A5 cells and (2) subsequent perfusion culture in a microfluidic device. With this 3D tissue construction approach, we replicated ex vivo, for the first time, the mechanotransduction function of human primary osteocytes and MLO-A5 cells by correlating the effects of cyclic compression on down-regulated SOST and DKK1 expressions. Also, as an example of using our ex vivo model to evaluate therapeutic agents, we confirmed previously reported findings that parathyroid hormone (PTH) decreases SOST and increases the ratio of RANKL and OPG. In comparison to other in vitro models, our ex vivo model: (1) replicates the cell density, phenotype, and functions of primary human osteocytes and MLO-A5 cells and (2) thus provides a clinically relevant means of studying bone diseases and metastases.

Indexed as

BiomimeticsBone and BonesBone Morphogenetic ProteinsCells, CulturedHumansMaleMechanotransduction, CellularMiddle AgedOsteocytesPhenotypeBone Morphogenetic Proteins3D bone tissueHuman primary osteocytesMechanotransductionParathyroid hormone (PTH)SOST/sclerostin

Identifiers

PMID29066313
PMCPMC5694355
OpenAlexW2766339731

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.